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Two disulfide-rich, low-molecular mass peptides (- 3 kDa and -4 kDa) have been isolated from Buthus sindicus venom using ion-exchange and 
reverse-phase HPLC. Peptide I has 35 residues with 8 half-cystine residues and is clearly related to four-disulfide core proteins of the neurophysin 
type and to toxins of other scorpion species (5563% residue identity). Peptide II, present in low yield, has 28 residues with 6 half-cystine residues 
and a structure Iargely dissimilar from that of peptide I and other characterized toxins, although probably still a member of the disulfide core 
peptide type. Consequently, scorpion venom contains, in addition to toxins characterized before, toxin-like compounds with distant relationships. 
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1, INTRODUCTION 
Scorpion venom is a mixture of largdy basic toxic 
polypeptides, containing 28-78 amino acid residues in 
single chains [l-4]. Several of these toxic polypeptides 
have been used for neurobiological studies [4] and for 
distinguishing ion channeIs [5]. Of the known scorpion 
families, toxins have been best characterized from 
Buthidae, where two main size groups have been 
found, one with 67-71 residues [6,7], the other with 
36-39 residues [8]. During investigation of the smaller 
group in the venom of Buthus sindicus from Sind, 
Pakistan, we purified two toxin-like peptides, one with 
35 residues and related to the previously characterized 
toxin from other species, the other with 28 residues and 
apparently not closely related. 
of the venom on a cation-exchange column (TSK CM-SPW, LKB) in 
20 mM sodium acetate, pH 4.5, with a linear gradient of O-O.5 M 
NaCl. It constitutes a minor fraction as shown in fig.1, and was 
rechromatographed on Vydac Cl8 to give the pure component, SDS- 
polyacrylamide gel electrophoresis utilized 15% gels with Tris- 
glycine, pH 8.3, 0.1% SDS. 
The two peptides were reduced with dithioerythritol and S- 
carboxymethylated with “C-labelIed iodoacetate in 0.4 M Tris-HCI 
(9f. Amino acid sequences were determined manually by the 
dimethylaminoazobenzene/phenylisothiocyanate double coupling 
method [lo], and by degradations with Beckman 890C and Applied 
Biosystems 470A sequencers. Phenylthiohydantoin derivatives were 
identified by liquid-phase chromatography [Ii]. Amino acid com- 
positions were determined with a Beckman 121M amino acid analyzer 
after hydrolysis with 6 M HCl/O.S% phenol at 110°C for 24 h. 
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2. MATERIALS AND METHODS I 
Venom was extracted from scorpion (Buthus sindicus) by electrical 
stimulation in deionized water, centrifuged at 10000 rpm, and 
N 
%016 
iy 
Iyophili~d. Peptide I, constituting a major fraction, was isolated by : 
direct HPLC of the crude venom on Vydac CL8 (Phenomenex, New 5 
York) in 0.1% trifluoroacetic acid with a linear gradient of 
:: 
acetonitrile. The peptide was recover.ed from peak Bus II of the elu- 
4” 
tion curve as shown in [12]. Peptide II was isolated by direct HPLC 
Correspondence address: A. Fazal, HE_i Research Institute of 
t 
L / / L  / 
- 
7 
IO 25 50 
Volumeiml) 
Chemistry, University of Karachi, Karachi-32, Pakistan 
The sequences presented here have been submitted to the 
EMBL/GenBank database under accession number YO7514 
Fig.1. Purification of peptide II from scorpion crude venom. 
Column: TSK CM-SPW in 20 mM sodium acetate, pH 4.5, and 
elution with a gradient (dashed line) of O-O.5 M NaCl. The arrow 
indicates the elution position of peptide II. 
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Peptide I: 
1 10 20 30 35 
RCKPCFTTDPQMSKKCADCCGGKGKGKCYGPQCLC 
Peptide II: 
Fig.2. Primary structures of scorpion 
November 1989 
1 10 20 28 
VGCEEDPMHCKGKQAKPTCCNGVCNCNV 
peptides I and II. Amino acid sequences were determined by direct degradation of the reduced and 
carboxymethylated polypeptides. 
3. RESULTS 
3.1. Peptide purification 
Crude venom was fractionated by cation-exchange 
HPLC and reverse-phase HPLC as given in section 2, 
to produce several components [121. Two of these pep- 
tides give a single band on SDS-polyacrylamide gel elec- 
trophoresis, with molecular mass ranges of 4 kDa for 
peptide I (purified as in [12]) and 3 kDa for peptide II 
(purified as shown in fig.1). Yields from venom were 
about 60 nmol for peptide I and 20 nmol of peptide II. 
Both peptides were pure as judged by N-terminal se- 
quence analysis, showing one structure in each case. 
3.2. Primary structure 
The amino acid sequences of both peptides were 
determined (fig.2). The two peptides were degraded to 
the C-termini by liquid-phase sequencer analysis for 
peptide I and gas-phase sequencer analysis for peptide 
II. Both structures are in excellent agreement with the 
compositions from acid hydrolysis (table 1). Positions 
of cysteine derivatives were confirmed by radioactivity 
of the extracts from degradation of the 14C- 
carboxymethyiated parent peptides. 
Table 1 
Amino acid composition of the scorpion venom peptides I and II 
Residues Peptide I Peptide II 
Cys(Cm) 7.7 (8) 6.0 (6) 
Asx 2.1 (2) 4.2 (4) 
Thr 2.5 (3) 1.0 (1) 
Ser 1.0 (1) _ 
Glx 2.0 (2) 3.0 (3) 
Pro 2.8 (3) 2.0 (2) 
GIY 4.8 (5) 3.0 (3) 
Ala 0.9 (1) 1.0 (1) 
Vat 2.8 (3) 
Met 0.9 (1) 1.2 (1) 
Leu 1.0 (1) - 
Tyr 0.9 (1) - 
Phe 1.0 (1) 
Lys 5.0 (5) 2.9 (3) 
His - 0.9 (1) 
Arg 1.0 (1) 
Sum 35 28 
Values are molar ratios after acid hydrolysis, and, within 
parentheses, the sums from the sequence analysis. Cys was 
determined as Cys(Cm) after reduction and carboxymethylation 
4. DISCUSSION 
Peptides I and II are not cIosely related, the smaller 
peptide II is not a fragment of the larger peptide I, and 
their half-cystine spacings are different. Thus, ~though 
both peptides belong to the smaller of the two peptide 
groups in scorpion venom [6], they differ substantially. 
Peptide I is a form related to the small toxic peptides 
previously characterized in scorpion venom [ 131. As 
shown in fig.3, it is similar to the venom peptide 
characterized from ~u~~u~ eupeus (Central Asian scor- 
pion), 21 of 35 residues are identical, and to that of An- 
droctonus mauretanicus, showing 24 identities. In all 
three cases, the half-cystine distributions are identical, 
suggesting conservation of folding patterns. However, 
considering the extensive conservation of other, small 
disulfide-linked toxins 191, the many residue 
replacements now found, with exchanges at close to 
half of all positions, is noteworthy. Apparently, func- 
tional requirements on the structure are not strict, 
allowing rapid evolutionary changes of the correspon- 
ding genes. 
Peptide I, and two previously characterized scorpion 
peptides, are related to neurophysins, agglutinins 
[14,15] and other peptides of the four-disulfide core 
protein family with the toxin/agglutinin fold. The com- 
mon pattern is shown in fig.4, showing simiiar half- 
cystine arrangements. Peptide II may also belong to 
this structural type although the end half-cystine 
residues appear to be missing as in other structures of 
this family (cf. fig.4). Consequently, although possibly 
a member of this group, peptide II is not closely related 
to the other members of the family and differs greatly 
in primary structure. Instead, judging from size and 
half-cystine content, it appears possible that peptide II 
correlates more closely with peptides isolated from 
Chactoid scorpions [l]. However, those peptides have 
apparently not been further analyzed, and relation- 
ships, if any, cannot yet be judged. Consequently, pep- 
tide II is thus far a peptide with unknown details of 
family affiliation. It should be noted that both peptides 
I and II are extremely rich in half-cystine residues and 
therefore tightly folded. This is also a typical property 
of other toxins, like for example the unrelated heat- 
stable bacterial toxins [9]. In all these cases, close to 
25% of all residues are half-cystine, presumably allow- 
ing extremely tight and stable folds. 
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Fig.3. Comparison of the peptide I structure with those of related peptides from other scorpion species [8,13]. Gaps are indicated by dashes and 
identical residues are boxed. 
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Fig.4. Similarities in half-cystine patterns of peptides I and II with those of other proteins of the four-disulfide core protein family [15]. In the 
case of peptide I, the homology is clear and the family assignment well supported. In the case of peptide II, alignment of primary structures 
provides few residue identities and little evidence beyond the half-cystine patterns shown. Numbers above Cys positions give numerical positions, 
while numbers between Cys positions show the number of intervening residues in each case. The peptide I structure is from fig.1, the other 
structures from [6]. 
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